AI-Driven Healthcare
Artrya (artrya.com) earns a Brand Analyzer score of 68 out of 100, placing it in the Developing tier among Healthcare brands, SaaS brands. Among 2305 Healthcare brands analyzed, Artrya ranks in the 49th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 95/100, Digital Presence 82/100, Visual Identity 93/100, Messaging Clarity 85/100, Trust Foundation 72/100, AI Discoverability 51/100, Brand Authority 19/100.
Artrya is a healthcare SaaS company that applies artificial intelligence to cardiovascular risk assessment. Its platform analyzes arterial plaque from coronary computed tomography angiography (CCTA) scans, providing physicians with rapid insights to stratify chest pain patients. The goal is to identify low-risk individuals quickly, enabling confident discharge decisions and reducing rates of undiagnosed coronary disease and heart attacks in communities. Artrya targets emergency and primary care settings.
| Brand Name | Artrya |
|---|---|
| Domain | artrya.com |
| Industry | Healthcare, SaaS |
| Main Competitors | Cleerly, HeartFlow, Viz.ai, Aidoc, Nanox |
Moz Domain Authority 24/100 vs category average 29 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #2,591,452 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Artrya aims to prevent undiagnosed coronary disease deaths by providing AI-driven plaque insights for rapid chest pain patient stratification." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: Microdata (Schema.org), og:title, og:image, og:type, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Instagram, YouTube, GitHub; no detected presence on X (Twitter), Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Artrya scores 18/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Artrya has a weak AI-visibility profile at 18/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (0/100). It benefits from a global traffic rank of #2,591,452 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 24/100.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Artrya's main competitors include Cleerly, HeartFlow, Viz.ai, Aidoc, Nanox. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Artrya official site
Popular alternatives to Artrya include Cleerly, HeartFlow, Viz.ai, Aidoc, Nanox. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Artrya official site
Artrya offers an AI-driven SaaS platform that analyzes arterial plaque from coronary computed tomography angiography (CCTA) scans. The platform is designed to provide plaque insights that enable rapid risk stratification of chest pain patients, helping physicians in emergency and primary care settings identify low-risk patients and make confident discharge decisions.
Sources: Artrya official site
Artrya has low AI-search visibility, scoring 18/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 23, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Artrya official site
Artrya uses artificial intelligence to analyze arterial plaque from coronary computed tomography angiography (CCTA) scans. Its platform delivers plaque insights that allow physicians to quickly stratify chest pain patients by risk level. By identifying low-risk patients rapidly, physicians can confidently discharge them, thereby reducing the incidence of missed coronary disease diagnoses and heart attacks within communities.
Sources: Artrya official site
Artrya is a healthcare SaaS company that develops AI-driven tools for cardiovascular risk assessment. It focuses on preventing deaths from undiagnosed coronary disease by providing physicians with rapid, data-driven insights into arterial plaque. The company positions itself as a leader in AI-powered cardiovascular risk assessment for emergency and primary care settings.
Sources: Artrya official site
Artrya and Cleerly are competitors in Healthcare. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Artrya official site
Artrya scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Artrya official site
Artrya's platform is designed for physicians and clinics that manage chest pain patients, specifically in emergency and primary care settings. These users rely on the AI-driven plaque analysis to make faster, more informed clinical decisions about patient risk stratification and discharge.
Sources: Artrya official site
Artrya can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Artrya official site
Artrya is known for its AI-powered analysis of arterial plaque derived from CCTA scans, specifically aimed at rapid stratification of chest pain patients in emergency and primary care environments. It is positioned as a leader in AI-driven cardiovascular risk assessment, with a stated mission of preventing deaths caused by undiagnosed coronary artery disease.
Sources: Artrya official site
Ranked closest to Artrya: Aranscia (68/100), Anterior (68/100), Ates Medical (68/100), Aveanna Healthcare (68/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).